Rightway Raises $155M to Expand AI-Powered Pharmacy Platform
Rightway Raises $155M Series E Funding Rightway has raised $155 million in Series E financing led by Francisco Partners. Existing investors Thrive Capital and Khosla Ventures also participated. The funding The post Rightway Raises $155M to Expand AI-Powered Pharmacy Platform appeared first on Ventureburn .
Rightway has secured $155 million in Series E funding led by Francisco Partners, with participation from existing investors Thrive Capital and Khosla Ventures. The company provides pharmacy benefit management and care navigation services to employers, now serving 45 Fortune 500 companies. The funding will support Rightway's next phase of growth as prescription drug spending continues to rise among large U.S. employers.
Rightway's SureSpend platform removes incentives for higher pharmacy spending, offering transparency through its Precision Pricing Guarantee and Zero-Markup Wrap, which covers high-cost drugs at true net cost. The platform also includes AI-powered healthcare technology to simplify medication decisions and provide personalized support.
Rightway's Chief Pharmacy Officer, Kristin Devlin, noted that pharmacists will have more time to focus on clinical work, helping members find appropriate treatments and manage medication concerns. The company's technology aims to reduce administrative costs and simplify healthcare decisions for members and plan sponsors, while connecting pharmacy management with broader care navigation services.
Written by urgent.news from Ventureburn's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
